Option: Abnormal Psychology 3 Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What is a disorder?

A

Disorder: a clinically significant disturbance in an individual’s cognition, emotional regulation, or behaviour.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are biological treatments of depression?

A

Antidepressants: medication which targets depressive symptoms by affecting the levels of neurotransmitters in the brain.

Neurotransmitters effecting depression:
- Seratonin (stabilizes mood and sleeping cycles)
- Fluoxetine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are psychological treatments of depression?

A

CBT: cognitive behavioural therapy:
- targets automatic thoughts and behaviour and adjusts them to being more rational and suited to the environment.

Interpersonal Psychotherapy: focuses on relieving symptoms of depression by improving interpersonal functioning.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Discuss one or more ways psychologists can assess the effectiveness of treatment.

A

Severity of the Disorder: some treatments work better with milder cases of depression, while others work better in severe cases.

Treatment Outcomes: observable reduction of symptoms (self reported improvement of quality of life)

The Time Frame: some treatments are more effective short-term while others are more effective long-term.

Method of Measuring: observable changes (do not capture the complexity of disorders), self-reported changes (less reliable).

Placebo Effect: method is effective if it outpreforms a placebo.

Response Rate: percentage of participants showing a decrease in standardized depression scales.

Remission Rates: percentage of participants who show little to no symptoms after their treatment period.

Relapse Rates: percentage of participants in which the past condition has reoccured (once treatment was discontinued).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which studies, and in what order, should be used in a question on the treatment of disorders?

A

1) Eysenk (no difference with and without treatment)
2) Glass and Smith (treated patients are healthier)
3) TADS (treatment is better than no treatment)
4) Elkin (treatment effectiveness differs between the severity of the disorder)
5) Hollon (treatment effectiveness differs in relapse rates)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the study completed by Eysenk et al.

A
  • reviewed available data and arrived at a conclusion that **PSYCHOTHERAPY DOES NOT WORK. **
  • he discovered that** 67%** of patients after 2 years have recovered without treatment, which is similar ro the rate of success in psychotherapy.
  • this research led to multiple attempts to testing the effectiveness of psycholtherapy.
  • it caused metaanalysis to emerge.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the study conducted by Glass and Smith.

A
  • conducted a metaanalyses on 375 studies (very carefully selected their bases of methodological quality)
  • concluded that: PSYCHOTHERAPY IS EFFECTIVE
  • a typical client was healthier than 75% percent of untreated individuals (compared to the 50% by random chance)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Discuss the study done by TADS.

A

AIM: to examine the short term and long term effectiveness of drug treatment and psychotherapy for depression.

PARTCIPANTS:
- 13 different clinics
- 439 participants of differing severity of depression.

PROCEDURE:
- longitudinal study
- 3 stages

1) Acute treatment for 12 weeks
- antidepressants alone (fluoxetine)
- CBT alone
- antidepressants and CBT
- placebo

2) Consolidation treatment 6 weeks
- clients from placebo changed treatment methods and were eiminated from the study.

3) Continuation of treatment 18 weeks
- assess the long-term effectiveness of treatment
- response rates were used to measure the effectiveness of treatment

RESULTS:
- all 3 active treatments outpreformed the pllacebo group.
- CBT usually reaches the same level of effectiveness as mediacation+CBT combined
- medication is more effective than psychotherapy in short-term but not long-term

EVALUATION:
Srengths:
- Easily replicated,
- medium population validity (large sample (439) and participant variability however USA sample that is underage)
- high ecological validity

Weaknessess:
- low internal validity
- low construct validity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the study conducted by Elkin et al.

A

AIM: to support the idea that the severity of depression must be taken into account when determining the effectiveness of treatment.

PARTCIPANTS:
- 250 patients

PROCEDURE:
- randomly allocated the participants into 1 of 4 groups:
1) antidepressants + clinical management
2) CBT
3) interpersonal psychotherapy
4) placebo + clinical management
- participants underwent treatment for 16 weeks.

RESULTS:
- all 3 active treatment conditions outpreformed the placebo.
- for milder cases of depression the 3 active treatments did not differ in effectiveness,
- for severe cases of depression antidepressands had an advantage.

CONCLUSION:
- the severity of depression is crucial to the determining the effectiveness of treatment

EVALUATION:
Srengths:
- high ecological validity
Weaknessess:
- ethics (some patients were not given treatment)
- low population validity (small sample)
- low internal validity (outside was not controlled)
- low construct validity (qualitative data)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Discuss the study conducted by Hollon et al.

A

AIM: to investigate the effectiveness of treatment (based on remission rates).

PARTCIPANTS:

PROCEDURE:
- participants were alocated into 1 of 3 groups:
1) CBT (all participants withdrawn after 12 months)
2) antidepressants (continued)
3) antidepressants (discontinued and switched to placebo pills)

RESULTS
- relapse rates were smallest in CBT,
- relapse rates were biggest in antidepressants which were switched for a placebo.
- CBT: enduring effect that extends beyond the end of treatment
- medication :often does not have an enduring effect

CONCLUSION:
- medication mainly targets the symptoms of depression but not the cause
- drugs are useful for short term management

EVALUATION:
Srengths:
- high ecological validity (pre-existing treatment)
- no demand characteristics

Weaknessess:
- ethics (harm)
- low generalizability (MDD symptoms vary across patients)
- low construct validity
- low internal validity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Discuss the role of culture in the treatment of disorders.

A

Culture: unique meaning and information system shared across a group of individuals and transmitted across generations.

Disorder: a clinically significant disturbance in an individual’s cognition, emotional regulation, or behaviour.

Depression: a mood disorder that causes a persistent feeling of sadness and loss of interest.

Studies to use: Kinzie et al.; Zhang et al.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the three cultural barriers to treatment?

A

1) Cognitive Barriers
2) Affective Barriers
3) Sociocultural Barriers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the Cognitive Barrier?

A

Cognitive barriers include beliefs that seeking professional psychological treatment is unnecessary, a sign of weakness, or ineffective.

  • Some ethnic minorities (Asian, Hispanic and African Americans) share the belief that mental hardships should be overcome by willpower, self control, and the endurance of difficulty without complaint.
  • People from different cultures may also doubt the effectiveness of modern Psychological treatment, and may prefer their own traditional healing or spiritual practices, such as prayer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the Affective Barrier?

A

Affective barriers include feelings of shame at seeking psychological help, or anxiety at being judged by others.
- In many cultures, there is still considerable stigma attached to mental illness, and so there can be a great deal of shame in being diagnosed with a disorder.
- Furthermore, in highly collective cultures (Asian cultures), seeking mental health treatment may be seen as an embarrassment to the entire family, suggesting that the family is somehow broken or dysfunctional.
- In some cases, there may be family pressure to avoid seeking treatment, in order to preserve the family reputation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the Sociocultural Barrier?

A

Sociocultural barriers include the reluctance to share personal and family problems with a stranger, particularly someone from a different culture.
- In order for therapy to be effective, a patient must be willing to open up and discuss sensitive emotional issues, and this may be difficult for people whose culture does not regard talking about problems as an effective way of overcoming them.
- In many cultures, family problems are to be kept strictly within the family, out of the need to preserve the reputation and social standing of the clan. In this context, discussing family dysfunction with outsiders could be considered a form of disloyalty.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Explain the study done by Kinzie et al.

A

AIM: Investigate cultural barriers to treatment for depression

PARTICIPANTS:
- 41 South-east Asian patients
- with depression
- who had been prescribed tricyclic antidepressants in U.S. clinics

PROCEDURE:
- Carried out blood tests
- The blood tests were intended to measure compliance with prescribed treatment

RESULTS:
- No sign of medication usage was detected in the blood of 61% of the patients
- Only 6 of the patients (15%) had therapeutic levels of antidepressants in their blood, indicating they were taking the medication often enough for it to be helpful

  • After a discussion session was held with patients, in which the benefits and side effects of medication were explained, compliance rates increased

CONCLUSION:
- There are cognitive and affective barriers to treatment of patients from different cultures, who may doubt the efficacy of Western psychiatric medicine, or view taking psychiatric medicine as shameful

  • On the other hand, ensuring that patients are well educated and informed about treatment can help overcome cultural barriers and improve treatment compliance

EVALUATION:
WEAKNESSESS:
- Low generalizibility: However, the sample size is relatively small (41), and involved only participants from South-East Asian countries, so it is questionable whether these results can be generalized to other minority groups
STRENGTHS
- By using blood tests, researchers were able to obtain objective measures of patient compliance with treatment.

17
Q

Explain the study done by Zhang et al.

A

AIM: Test the effictiveness of Chinese Taoist cognitive psychotherapy (CTCP), in treating patients with generalized anxiety disorder (GAD).

Chinese Taoist Cognitive Psychotherapy: an indigenous therapy combining aspects of cognitive therapy and Taoist philosophy.

PARTICIPANTS:
- 143 patients with generalized anxiety disorder (GAD)

PROCEDURE:
Patients were randomly assigned to recieve either:
- CTCP (Chinese Taoist cognitive psychotherapy)
- an anxiety relieving medication (BDZ)
- both

patients were assessed:
- 1 month
- 6 months
after recieving treatment.

RESULTS:
- Patients on anxiety relieving medication (BDZ) improved rapidly after one month, BUT the improvement was not sustained after six months

  • Patients receiving CTCP did not show much improvement after one month, BUT significant improvement after 6 months, (including improved coping style and lower neuroticism)
  • Patients receiving both medication and therapy showed improvement at both the one month and six month intervals

CONCLUSION:
- While medication can deliver short-term reduction in symptoms, CTCP is more effective for long-term treatment of generalized anxiety disorder

18
Q

Griner and Smith (2016)

A

AIM: To examine the benefit of culturally adapted treatments:

PARTICIPANTS: 25,000 participants

METHOD: Meta analysis of 76 studies (with 25,000 total participants).

RESULTS:
- There is a strong benefit to culturally adapting CBT.
- The average effect size was 0.45.
- The effect size was lowered to 0.14 in mixed race groups.
- Older participants were more responsive to culturally adapted therapy.
- Treatments were more effective in the participant’s native language (when conducted in English, the effect size was 0.21).

CONCLUSION: Cultural adaptations for specific sub populations are most effective.
The age difference reflects varying levels of acculturation across generations.

EVALUATION:
Strength:
- Results were compared to those of unpublished studies (and the same results were observed) to eliminate publication bias.
- high population validity

Weaknessess:
- low construct validity